title: Evolving role of bone biomarkers in castration-resistant prostate cancer.
abstract: The preferential metastasis of prostate cancer cells to bone disrupts the process of bone remodeling and results in lesions that cause significant pain and patient morbidity. Although prostate-specific antigen (PSA) is an established biomarker in prostate cancer, it provides only limited information relating to bone metastases and the treatment of metastatic bone disease with bisphosphonates or novel noncytotoxic targeted or biological agents that may provide clinical benefits without affecting PSA levels. As bone metastases develop, factors derived from bone metabolism are released into blood and urine, including N- and C-terminal peptide fragments of type 1 collagen and bone-specific alkaline phosphatase, which represent potentially useful biomarkers for monitoring metastatic bone disease. A number of clinical trials have investigated these bone biomarkers with respect to their diagnostic, prognostic, and predictive values. Results suggest that higher levels of bone biomarkers are associated with an increased risk of skeletal-related events and/or death. As a result of these findings, bone biomarkers are now being increasingly used as study end points, particularly in studies investigating novel agents with putative bone effects. Data from prospective clinical trials are needed to validate the use of bone biomarkers and to confirm that marker levels provide additional information beyond traditional methods of response evaluation for patients with metastatic prostate cancer.
authors.affiliation: Cancer Research UK Clinical Centre, University of Leeds, Leeds, UK. j.e.brown@leeds.ac.uk
authors.forename: Janet E
authors.initials: JE
authors.lastname: Brown
authors.forename: Sheryl
authors.initials: S
authors.lastname: Sim
mesh_terms: D014408:Biomarkers, Tumor / Q000097:blood / Q000378:metabolism / Q000502:physiology* / Q000652:urine; D001859:Bone Neoplasms / Q000175:diagnosis / Q000378:metabolism / Q000556:secondary; D001842:Bone and Bones / Q000378:metabolism*; D002277:Carcinoma / Q000175:diagnosis* / Q000378:metabolism / Q000473:pathology / Q000628:therapy; D006801:Humans; D008297:Male; D008954:Models, Biological; D058990:Molecular Targeted Therapy / Q000379:methods / Q000639:trends; D009919:Orchiectomy / Q000379:methods; D011237:Predictive Value of Tests; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000378:metabolism / Q000473:pathology / Q000628:therapy; D017211:Treatment Failure
chemical_list: D014408:Biomarkers, Tumor
references.citation: Osteoporos Int. 2011 Jan;22(1):369-70
references.pmid: 20306021
references.citation: Nat Clin Pract Oncol. 2005 Oct;2(10):504-17; quiz 1 p following 533
references.pmid: 16205770
references.citation: Clin Cancer Res. 2008 Oct 1;14(19):6302-9
references.pmid: 18829513
references.citation: Proteomics. 2005 Aug;5(13):3329-42
references.pmid: 16052622
references.citation: J Natl Cancer Inst. 2002 Oct 2;94(19):1458-68
references.pmid: 12359855
references.citation: Cancer. 2007 Oct 15;110(8):1860-7
references.pmid: 17763372
references.citation: Clin Genitourin Cancer. 2007 Sep;5(6):390-6
references.pmid: 17956712
references.citation: Calcif Tissue Int. 1991 Dec;49(6):421-6
references.pmid: 1818768
references.citation: Clin Chem. 1994 Nov;40(11 Pt 1):2022-5
references.pmid: 7955372
references.citation: Br J Cancer. 2000 Feb;82(4):858-64
references.pmid: 10732759
references.citation: Clin Chem. 1996 Jun;42(6 Pt 1):947-54
references.pmid: 8665688
references.citation: Clin Chem. 1999 Aug;45(8 Pt 2):1359-68
references.pmid: 10430819
references.citation: Clin Cancer Res. 2006 Oct 15;12(20 Pt 2):6213s-6216s
references.pmid: 17062703
references.citation: J Clin Oncol. 1998 May;16(5):1835-43
references.pmid: 9586898
references.citation: Cancer Res. 2005 Oct 15;65(20):9185-9
references.pmid: 16230377
references.citation: Clin Chem. 1990 Jul;36(7):1328-32
references.pmid: 2372946
references.citation: Acta Oncol. 2006;45(2):216-7
references.pmid: 16546871
references.citation: N Engl J Med. 2004 Apr 15;350(16):1655-64
references.pmid: 15084698
references.citation: Expert Rev Proteomics. 2007 Jun;4(3):371-8
references.pmid: 17552921
references.citation: Clin Chem. 2009 Apr;55(4):765-73
references.pmid: 19233911
references.citation: Ann Oncol. 2008 Sep;19 Suppl 7:vii91-5
references.pmid: 18790987
references.citation: N Engl J Med. 2009 Mar 26;360(13):1320-8
references.pmid: 19297566
references.citation: Cancer Treat Rev. 2008 Nov;34(7):629-39
references.pmid: 18579314
references.citation: Clin Cancer Res. 2008 Oct 1;14(19):6270-6
references.pmid: 18829508
references.citation: Prostate. 2009 May 1;69(6):624-32
references.pmid: 19143027
references.citation: Mol Cancer Res. 2009 Apr;7(4):476-88
references.pmid: 19372577
references.citation: J Natl Cancer Inst. 2005 Jan 5;97(1):59-69
references.pmid: 15632381
references.citation: Cancer. 2000 Jun 15;88(12 Suppl):2989-94
references.pmid: 10898342
references.citation: CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49
references.pmid: 19474385
references.citation: Int J Cancer. 2004 Sep 20;111(5):783-91
references.pmid: 15252851
references.citation: Cancer Res. 2009 Jan 1;69(1):151-60
references.pmid: 19117998
references.citation: Cancer. 2007 Mar 15;109(6):1090-6
references.pmid: 17311345
references.citation: Oncologist. 2009 Aug;14(8):816-27
references.pmid: 19684076
references.citation: Expert Rev Proteomics. 2005 Oct;2(5):693-703
references.pmid: 16209649
references.citation: J Clin Oncol. 2003 Feb 15;21(4):679-89
references.pmid: 12586806
references.citation: J Bone Miner Res. 1992 Nov;7(11):1251-8
references.pmid: 1466251
references.citation: Cancer. 2007 Nov 1;110(9):1959-66
references.pmid: 17886253
references.citation: J Clin Oncol. 2005 Aug 1;23(22):4925-35
references.pmid: 15983391
references.citation: Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3361-7
references.pmid: 16740758
references.citation: Hum Pathol. 2000 May;31(5):578-83
references.pmid: 10836297
references.citation: J Bone Miner Res. 1994 Oct;9(10):1643-9
references.pmid: 7817812
references.citation: Clin Chem. 2001 Mar;47(3):597-600
references.pmid: 11238321
references.citation: Lancet Oncol. 2009 Mar;10(3):233-9
references.pmid: 19213602
references.citation: Clin Cancer Res. 2001 Dec;7(12):4060-6
references.pmid: 11751502
references.citation: Cancer. 2002 Sep 1;95(5):1028-36
references.pmid: 12209687
references.citation: Prostate. 2006 Apr 1;66(5):503-13
references.pmid: 16372331
references.citation: J Clin Oncol. 2007 Nov 20;25(33):5313-8
references.pmid: 17925542
references.citation: Cancer. 2003 Feb 1;97(3 Suppl):779-84
references.pmid: 12548575
references.citation: J Natl Cancer Inst. 1998 Jul 1;90(13):1000-8
references.pmid: 9665149
references.citation: Clin Cancer Res. 2007 Jun 1;13(11):3244-9
references.pmid: 17545529
references.citation: Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):32-8
references.pmid: 16434583
references.citation: Clin Chem. 1996 Nov;42(11):1796-804
references.pmid: 8906079
references.citation: J Bone Miner Res. 2010 Mar;25(3):463-71
references.pmid: 19775203
references.citation: Cancer Res. 1997 Dec 15;57(24):5517-20
references.pmid: 9407961
references.citation: Lancet Oncol. 2007 Jul;8(7):587-94
references.pmid: 17544845
references.citation: Clin Cancer Res. 2008 Jan 1;14(1):209-14
references.pmid: 18172272
references.citation: Eur Urol. 2005 Dec;48(6):1031-41
references.pmid: 16054748
references.citation: Calcif Tissue Int. 1998 Aug;63(2):102-6
references.pmid: 9685512
references.citation: N Engl J Med. 2004 Oct 7;351(15):1513-20
references.pmid: 15470214
references.citation: Cancer. 2000 Jun 15;88(12 Suppl):2961-78
references.pmid: 10898340
references.citation: J Clin Oncol. 2009 May 20;27(15):2450-6
references.pmid: 19380444
references.citation: Eur Urol. 2009 May;55(5):1112-23
references.pmid: 19042080
references.citation: J Bone Miner Res. 2003 May;18(5):859-67
references.pmid: 12733725
references.citation: J Clin Endocrinol Metab. 2003 Nov;88(11):5059-75
references.pmid: 14602728
references.citation: Cancer. 2008 Jul 1;113(1):193-201
references.pmid: 18459173
references.citation: Anticancer Res. 2009 Feb;29(2):671-3
references.pmid: 19331219
references.citation: Cancer. 2006 Aug 1;107(3):530-5
references.pmid: 16804927
references.citation: Support Cancer Ther. 2005 Jul 1;2(4):234-40
references.pmid: 18628179
references.citation: Clin Cancer Res. 2007 Dec 1;13(23):7053-8
references.pmid: 18056182
references.citation: J Clin Oncol. 2009 May 20;27(15):2429-35
references.pmid: 19364971
references.citation: Ann Oncol. 2009 May;20(5):913-20
references.pmid: 19403935
references.citation: BJU Int. 2001 Mar;87(4):348-51
references.pmid: 11251528
references.citation: Acta Oncol. 2007;46(2):221-9
references.pmid: 17453373
references.citation: Cancer Treat Rev. 2001 Jun;27(3):165-76
references.pmid: 11417967
references.citation: Eur Urol. 2007 Nov;52(5):1381-7
references.pmid: 17321667
references.citation: J Clin Endocrinol Metab. 1990 Aug;71(2):442-51
references.pmid: 2380339
references.citation: Cancer. 2006 Jul 15;107(2):289-98
references.pmid: 16752412
references.citation: Bone. 1996 Aug;19(2):157-63
references.pmid: 8853860
references.citation: Ann Oncol. 2007 Mar;18(3):581-92
references.pmid: 17287242
references.citation: J Urol. 2007 Sep;178(3 Pt 1):849-53; discussion 853; quiz 1129
references.pmid: 17631330
references.citation: Int J Clin Pract. 2009 Jan;63(1):19-26
references.pmid: 19125989
references.citation: J Urol. 2009 Aug;182(2):509-15; discussion 515-6
references.pmid: 19524963
references.citation: Clin Chem. 2001 Apr;47(4):747-9
references.pmid: 11274028
references.citation: N Engl J Med. 2004 Oct 7;351(15):1502-12
references.pmid: 15470213
references.citation: Curr Opin Urol. 2008 May;18(3):303-8
references.pmid: 18382240
references.citation: Cancer. 1997 Oct 15;80(8 Suppl):1588-94
references.pmid: 9362426
references.citation: Clin Chem. 1993 Apr;39(4):635-40
references.pmid: 8472358
references.citation: Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10954-9
references.pmid: 12941866
references.citation: J Clin Oncol. 2008 Mar 1;26(7):1148-59
references.pmid: 18309951
references.citation: Bone. 1995 Apr;16(4):461-7
references.pmid: 7605707
references.citation: J Urol. 2003 Mar;169(3):1143-9
references.pmid: 12576870
references.citation: Clin Chem. 1987 Apr;33(4):458-62
references.pmid: 3829376
references.citation: Anticancer Res. 2005 Mar-Apr;25(2B):1457-63
references.pmid: 15865105
references.citation: Osteoporos Int. 2000;11 Suppl 6:S18-29
references.pmid: 11193236
references.citation: Ann Clin Biochem. 2000 Jul;37 ( Pt 4):432-46
references.pmid: 10902858
references.citation: Leukemia. 2009 May;23(5):994-7
references.pmid: 19092851
references.citation: Cancer Treat Rev. 2001 Jun;27(3):187-92; discussion 193-6
references.pmid: 11417970
references.citation: Clin Chem. 1995 Nov;41(11):1560-6
references.pmid: 7586543
references.citation: Ann Oncol. 2005 Apr;16(4):579-84
references.pmid: 15734776
references.citation: Invest New Drugs. 2011 Feb;29(1):118-25
references.pmid: 19763400
references.citation: Dis Markers. 2006;22(4):245-55
references.pmid: 17124346
references.citation: Mol Cancer Ther. 2007 Oct;6(10):2609-17
references.pmid: 17938257
references.citation: J Natl Cancer Inst. 2004 Jun 2;96(11):879-82
references.pmid: 15173273
references.citation: Cancer Biomark. 2006;2(6):249-58
references.pmid: 17264396
references.citation: J Clin Oncol. 2009 May 20;27(15):2436-42
references.pmid: 19364960
references.citation: Anal Biochem. 2003 Jul 15;318(2):204-11
references.pmid: 12814623
references.citation: Clin Cancer Res. 2009 Dec 1;15(23):7421-8
references.pmid: 19920114
references.citation: J Clin Oncol. 2007 Sep 1;25(25):3965-70
references.pmid: 17761981
references.citation: Clin Chem. 2005 Apr;51(4):695-707
references.pmid: 15695329
references.citation: J Med Chem. 2004 Dec 30;47(27):6658-61
references.pmid: 15615512
references.citation: Anticancer Drugs. 2009 Mar;20(3):179-84
references.pmid: 19396016
references.citation: Clin Chem. 1996 Oct;42(10):1639-44
references.pmid: 8855148
references.citation: Leukemia. 2009 Mar;23(3):590-4
references.pmid: 18784745
references.citation: J Clin Oncol. 2009 Apr 1;27(10):1564-71
references.pmid: 19237632
references.citation: J Bone Miner Res. 2010 Mar;25(3):440-6
references.pmid: 19653815
references.citation: Clin Chem. 1997 Nov;43(11):2076-82
references.pmid: 9365391
references.citation: Ann Oncol. 2010 Sep;21(9):1864-1869
references.pmid: 20181574
references.citation: Cancer Res. 2008 May 1;68(9):3323-33
references.pmid: 18451159